c
2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
89
30
1d
2 29
1d
25
30
Kevin G. Lynch, PhD
b5Associate Professor of Biostatistics in Psychiatry at the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia
7
61
Department: Psychiatry
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
62
4
3
3
1d
62
3535 Market Street, #5099
Philadelphia, PA 19104
26
Philadelphia, PA 19104
2e
Office: 215-746-7707
30
9b
12
30
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 a B.Sc. 18 (Mathematics) c
3d University College, Galway, Ireland , 1988.
21 a M.Sc. 27 (Mathematics and Statistics) c
3e University College, Galway, Ireland , 1989.
21 9 M.A. 17 (Statistics) c
29 Yale University , 1990.
21 9 Ph.D 17 (Statistics) c
29 Yale University , 1997.
c
3
27
21 a B.Sc. 18 (Mathematics) c
3d University College, Galway, Ireland , 1988.
21 a M.Sc. 27 (Mathematics and Statistics) c
3e University College, Galway, Ireland , 1989.
21 9 M.A. 17 (Statistics) c
29 Yale University , 1990.
21 9 Ph.D 17 (Statistics) c
29 Yale University , 1997.
c
Links
98 Search PubMed for articles
d
5
3
3
8f
Permanent link98 Search PubMed for articles
d
2 29
21
1e
1d
24
5e
26 29
27
Description of Research Expertise
1d biostatistics26 29
23
165 Joshi SA, Lin T, Balderston N, Lynch KG, Tang M, Patel M, Fureman B, Oathes D, Gregory D, Sheline Y, and Brown LA: A mechanistic trial of the neurobiology of extinction learning and intraparietal sulcus stimulation: Protocol. The Journal of Medical Internet Research 49: 101591, 2026.
19b Evans DL, Spitsin S, Lynch KG,Voytek CD, Daramay MG, Hembree EA, Fiore D, Gross R, Scott JC, Douglas SD, and Thase ME: A Placebo-Controlled Randomized Trial of the Effects of Escitalopram on Depressive Symptoms and Immune Function in People with Human Immunodeficiency Virus. Biological Psychiatry: Global Open Science 6(1): 100627, 2026.
104 Pham C, Lynch KG, McKay, J, and Ertefaie A: Sensitivity analysis for constructing optimal regimes in the presence of treatment non-compliance. Electronic J Statistics 19: 2005-2120, 2025.
122 Becker-Haimes E, Mandell DS, Kuo P, Lynch KG, Brady M, Young S, and Creed T: BEhavioral Nudges to Enhance Fidelity in Telehealth Sessions (BENEFITS): Protocol for developing and pilot testing a telehealth tool to improve CBT implementation 2 42 JMIR Research Protocols 14: e76035, 2025.
175 Hain D, Del Tredici AL, Griggs RB, Law R, Mabey B, Johnson H, Johansen Taber K, Lynch KG, Gutin A, and Oslin DW : Impact of pharmacogenomic testing on time-to-remission from depression: a time-to-event analysis of the PRIME Care randomized trial. Frontiers in Psychiatry. (eds.). 16: 1658616, 2025.
15d Vest BM, Wray LO, Hull LE, Lynch KG, Chapman SR, Thase ME, Ramsey C, Simonetti J, Oslin DW : The perceived value of pharmacogenetic testing in the treatment of depression: Mixed methods results from the PRIME Care Study. Psychiatric Services. (eds.). 76(6): 589-597, 2025.
14b Sheline YI, Thase M, Hembree E, Balderston N, Nichie F, Batzdorf A, Makhoul W, and Lynch KG : Neuroimaging Changes in Major Depression with Brief Computer-Assisted Cognitive Behavioral Therapy Compared to Waitlist. Molecular Psychiatry 30: 3579–3587, 2025.
142 Brown LA, Lynch KG, Gehrman P, Farabaugh D, and Mayinja L., and , Bredemeier K: Suicidal ideation, cognitive control and sleep in Veterans in a residential treatment facility: A pilot study. Suicide and Life-Threatening Behavior 55(2): e70011, 2025.
159 Kranzler HR, Stone A, Schichman S, Griffin LM, Pfeifer J, Lynch KG, and Oslin DW: Macrophage Migration Inhibitory Factor and Interleukin 1- β RNA Levels as Predictors of Antidepressant Treatment Response in Major Depression. Psychopharmacology Bulletin 55(1): 8-25, 2025.
2c
7
1d
1f
Selected Publications
174 Shi Z, Wang A-L, Liu J, Audrain-McGivern J, Lynch KG, Loughead J, and Langleben D. Li X, Todaro DR, Cao W, Lynch KG, Detre JA, Loughead J, Langleben DD, and Wiers CE : Delayed effects of cigarette graphic warning labels on smoking behavior. American Journal of Health Promotion 40(2): 229-234, 2026.165 Joshi SA, Lin T, Balderston N, Lynch KG, Tang M, Patel M, Fureman B, Oathes D, Gregory D, Sheline Y, and Brown LA: A mechanistic trial of the neurobiology of extinction learning and intraparietal sulcus stimulation: Protocol. The Journal of Medical Internet Research 49: 101591, 2026.
19b Evans DL, Spitsin S, Lynch KG,Voytek CD, Daramay MG, Hembree EA, Fiore D, Gross R, Scott JC, Douglas SD, and Thase ME: A Placebo-Controlled Randomized Trial of the Effects of Escitalopram on Depressive Symptoms and Immune Function in People with Human Immunodeficiency Virus. Biological Psychiatry: Global Open Science 6(1): 100627, 2026.
104 Pham C, Lynch KG, McKay, J, and Ertefaie A: Sensitivity analysis for constructing optimal regimes in the presence of treatment non-compliance. Electronic J Statistics 19: 2005-2120, 2025.
122 Becker-Haimes E, Mandell DS, Kuo P, Lynch KG, Brady M, Young S, and Creed T: BEhavioral Nudges to Enhance Fidelity in Telehealth Sessions (BENEFITS): Protocol for developing and pilot testing a telehealth tool to improve CBT implementation 2 42 JMIR Research Protocols 14: e76035, 2025.
175 Hain D, Del Tredici AL, Griggs RB, Law R, Mabey B, Johnson H, Johansen Taber K, Lynch KG, Gutin A, and Oslin DW : Impact of pharmacogenomic testing on time-to-remission from depression: a time-to-event analysis of the PRIME Care randomized trial. Frontiers in Psychiatry. (eds.). 16: 1658616, 2025.
15d Vest BM, Wray LO, Hull LE, Lynch KG, Chapman SR, Thase ME, Ramsey C, Simonetti J, Oslin DW : The perceived value of pharmacogenetic testing in the treatment of depression: Mixed methods results from the PRIME Care Study. Psychiatric Services. (eds.). 76(6): 589-597, 2025.
14b Sheline YI, Thase M, Hembree E, Balderston N, Nichie F, Batzdorf A, Makhoul W, and Lynch KG : Neuroimaging Changes in Major Depression with Brief Computer-Assisted Cognitive Behavioral Therapy Compared to Waitlist. Molecular Psychiatry 30: 3579–3587, 2025.
142 Brown LA, Lynch KG, Gehrman P, Farabaugh D, and Mayinja L., and , Bredemeier K: Suicidal ideation, cognitive control and sleep in Veterans in a residential treatment facility: A pilot study. Suicide and Life-Threatening Behavior 55(2): e70011, 2025.
159 Kranzler HR, Stone A, Schichman S, Griffin LM, Pfeifer J, Lynch KG, and Oslin DW: Macrophage Migration Inhibitory Factor and Interleukin 1- β RNA Levels as Predictors of Antidepressant Treatment Response in Major Depression. Psychopharmacology Bulletin 55(1): 8-25, 2025.
2c
51
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10